Hyperpolarization turns typically weak NMR and MRI responses into strong signals so that ordinarily impractical measurements become possible. The potential to revolutionize analytical NMR and clinical diagnosis through this approach reflect this area's most compelling outcomes. Methods to optimize the low cost parahydrogen based signal amplification by reversible exchange (SABRE) approach through studies on a series of biologically relevant nicotinamides and methyl nicotinates are first detailed. These procedures involve specific 2 H-labelling in both the agent and catalyst and achieve polarization lifetimes of ca. 2 minutes with 50% detectability in the case of 4,6-d 2 -nicotinate. As a 1.5 T hospital scanner has an effective 1 H detectability level of just 0.0005% this strategy should result in compressed detection times for chemically discerning measurements that probe disease. To demonstrate this techniques generality, we exemplify further studies on a range of pyridazine, pyrimidine, pyrazine and isonicotinamide analogues that feature as building blocks in biochemistry and many disease treating drugs.
Introduction
By harnessing the magnetic properties of nuclei, we unlock nuclear magnetic resonance (NMR), one of the most powerful methods available for studying materials, which in the form of magnetic resonance imaging (MRI) revolutionizes clinical diagnosis.(1) One simple route to improve the diagnostic capabilities of MRI involves monitoring in vivo changes in metabolite flux in conjunction with spatially resolved measurements to non-invasively probe human physiology. (2) However, for reasons of low sensitivity, agent detection needs to be coupled with approaches to increase detectability.(3) This process is exemplified by studies on pyruvate which harnesses dissolution dynamic nuclear polarization (DNP) (4) to produce the signal strength necessary to track its metabolism. Additionally, the related method of optical pumping noble gases, such as 129 Xe,(5) has provided the sensitivity needed to produce lung MR images that probe pulmonary disease.
Both of these agents magnetic resonance (MR) detectability was greatly increased through a process known as hyperpolarization. However, the associated hyperpolarization step could be viewed as being complex. (6, 7) One related method of great promise is that of MR enhancement by parahydrogen (p-H 2 ). (8, 9) p-H 2 is a unique hyperpolarized feedstock which has no magnetic moment and is not observed itself.(10) Instead, a highly visible agent is obtained when it adds to an unsaturated center as a consequence of this chemical change. (10) The resulting products' intrinsic magnetization, more commonly referred to as polarization, can lie so far from thermodynamic equilibrium that measurements which normally take months become possible in seconds.(11) However, this is only possible if the agent's highsensitivity monitoring takes place before relaxation returns its polarization to the more usual weak-signal level. Moreover, the associated magnetization can be examined just once at high sensitivity because the hyperpolarization process takes place outside the final readout-area. Hence the imaging of such agents after dosing in a clinical setting must be very rapid if the strong response is to survive the time taken to travel to this location. The development of this technique is, therefore fraught with experimental challenge as fresh samples are needed for each study. Furthermore, the use of NMR spectroscopy as an analytical tool would also benefit substantially if the materials it analyses can be rapidly characterized at lower concentrations than is currently possible. (12) (13) (14) Hence, harnessing the fruits of hyperpolarization will provide opportunities to improve our ability to study materials in a very wide range of applications.
In this study, we illustrate a number of new developments to dramatically improve the p-H 2 based method Signal Amplification By Reversible Exchange (SABRE). (15) This route shows great promise for contributing significantly to both analytical NMR and clinical diagnosis in the future.(16-21) SABRE does not change the chemical identity of the agent it hyperpolarizes, it simply equilibrates polarization between p-H 2 and the selected agent to create highly visible signals through earlier binding to a metal center. (15) This simple and cheap to implement process is shown schematically in Fig. 1 with the reproducible response being created in just a few seconds. (22) Furthermore, as it maintains its hyperpolarization while in the presence of p-H 2 it can maintain its polarization level for many minutes in low field as it can be continually replenished (22, 23) . Consequently we predict that the future in vivo optimization of this method will be easier than that of many other approaches if we can deliver agents with high signal strengths and appropriately long-lived magnetization.
Fig. 1. Schematic representation of the SABRE effect
We present here a general strategy to achieve this aim by combining a series of breakthroughs in substrate and catalyst design. We illustrate this strategy through studies on nicotinamide (1) and methyl nicotinate (2) , and a series of their selectively deuterated analogues, before demonstrating the approaches wider applicability. These two agents exhibit low toxicity and play important roles in cellular biology and hence are biochemically important targets. (24) The relaxation times and hyperpolarization levels of these biocompatible agents are shown to be dramatically increased by the selective use of spindilution through appropriate 2 H-labelling, a strategy that has already be deployed for DNP. (25) We overcome the fact that the SABRE catalyst ultimately reduces the levels of hyperpolarization through transfer to H 2 when p-H 2 is a limiting reagent (26) by improving on the lifetime of the agents' magnetization when bound to the catalyst through 2 H-labelling of its ancillary ligands. Subsequently, we show that by combining these strategic advances 50% hyperpolarization can be achieved in conjunction with magnetic-state lifetimes that approach 100 seconds for a 2 H-labelled nicotinate. By expanding the scope of this strategy to other target agents we show that a universal improvement in 1 H hyperpolarization level and relaxation time is achieved. The single-scan MRI detection of these agents is then used to reveal that these improvements facilitate the acquisition of images whose intensity and contrast are vastly superior to those without hyperpolarization. Whilst the relaxation times of these agents are reduced in H 2 O solution, they still exhibit high detectability when compared to the results of normal study. Hence we are confident that the results presented here reflect a series of key steps towards successful in vivo SABRE whilst also serving to improve its potential as analytical tool for NMR.
Results and discussion
The SABRE method starts by dissolving an agent (substrate) in a solvent that contains a metal based polarization transfer catalyst and then exposing it to p-H 2 for a few seconds in low magnetic field. The hyperpolarized agent can then be detected in a second step by NMR or MRI methods. Protio-nicotinamide (1) was one of the first substrates to be polarized by SABRE (15) and aspects of its 1 H, 13 C and 15 N signal enhancement have been previously communicated.(27-31). When 1 is hyperpolarized in this way through SABRE(28) in methanol-d 4 solution, as detailed in the supporting information, the signal for H-2 is ca. 650 times larger than that observed in a control measurement under Boltzmann conditions at a 9.4 T field. In contrast, the corresponding signals for H-4, H-5 and H-6 are 620, 190 and 590 times larger respectively than those of the H-2 control signal. Fig. 2 -left illustrates a typical measurement. This signal intensity corresponds to detecting 2.1% H-2 polarization, created after a combination of just 7 seconds exposure to 3 bar of p-H 2 and three seconds for subsequent transfer into the measurement field. The corresponding polarization values in ethanol-d 6 range from 1.1 to 0.1% as detailed in Table 1 . It is therefore straightforward to conclude that 1 is highly amenable to SABRE. Furthermore, according to the laws of signal averaging, if 31 seconds were needed to repeat each control measurement, it would take ca. 150 days of data collection to reproduce the previously detailed hyperpolarized result if a normal signal were to be employed. It is for this reason that hyperpolarization represents a platform that could radically transform clinical diagnosis and analytical NMR more generally. (Table 1) ; the normal trace has a x8 vertical expansion relative to the hyperpolarized trace (all measurements were performed in ethanol-d6).
As we have indicated though, this signal gain must survive to the point of measurement. In methanol-d 4 solution, the four distinct protons resonances of 1, H-2, H-4, H-5 and H-6, have T 1 values of 16.3, 11.3, 6.9 and 9.8 seconds at 9.4 T respectively (see Table 1 , errors are <5% unless specified). These T 1 values change to 23.3 (50% increase), 6.7 (40% fall), 3.9 (45% fall) and 7.8 (20% fall) seconds respectively in ethanol-d 6 solution, and range from 10.7 to 6.5 seconds in D 2 O solution. Hence these values are highly solvent dependent and not, at first glance, likely to be ideal for in vivo imaging; due to low SABRE efficiency in neat D 2 O solutions the corresponding polarization levels are not reported.(32, 33)
Relaxation during SABRE catalysis
Examination of these NMR relaxation properties under SABRE conditions reveals that the observed T 1 values for the four proton signals of 1 reduce to just 6.2, 6.3, 3.7 and 3.8 seconds respectively in methanol-d 4 . Furthermore, the H-2 T 1 value in ethanol-d 6 falls by 83% to 4.2 seconds thereby implying even faster signal destruction. These changes are explained by the role the SABRE catalyst plays in facilitating the reversible flow of polarization according to Fig. 1 . During SABRE, rapid polarization transfer is beneficial, in leading to a large signal gain but at high field, or without p-H 2 , the catalyst clearly destroys the contrast agents' hyperpolarization by reducing T 1 .
Using 2 H-labelling to reduce agent relaxation
Initially, we proposed to overcome these effects by using 2 Hlabelling to extend the proton relaxation times of 1.(27) Hence, nicotinamide derivatives 1a-1g were prepared using the methods described in Fig. 3 . These synthetic routes have been scaled to provide over 25 grams of the desired isotopologue and thus provide a robust platform to underpin any potential clinical/pre-clinical studies. Table 1 presents their SABRE performance and proton T 1 values, both with and without catalyst, at 9.4 T in methanol-d 4 , ethanol-d 6 and D 2 O solutions and clearly there is a beneficial extension in T 1 . Fig. 3 . Synthetic methods used to prepare agents 1a-1g. Yields are isolated yields after column chromatography.
As these structures all contain fewer protons than 1, they might be expected to achieve higher polarization levels under conditions when p-H 2 is the limiting reagent. However, substrate 1a, whose ortho protons have been removed, gives low polarization under SABRE conditions. We conclude, therefore, that 1a has polarization acceptor sites that are too magnetically isolated from the hydride ligands of the catalyst for effective SABRE transfer. In contrast, forms 1b-1g all possess a proton adjacent to nitrogen, and based on the recent study by Tessari et al., the relative position of the ortho proton to the ring substituent is unlikely to affect its coupling with the hydride ligand in the catalyst.(34) They should therefore all receive polarization at a similar rate and hence the poor performance of 1c under SABRE must be a consequence of rapid relaxation. Agents 1e and 1f have the largest average T 1 values of the series and perform best under SABRE. 1e possesses a 4 J coupling between protons H-4 and H-6 that facilitates magnetization transfer between them and gives hyperpolarization levels of 2.7 and 3.2% respectively in methanol-d 4 (Fig. 1 ). For 1f, the corresponding weaker 5 J coupling between protons H-2 and H-5 now results in 4.1% hyperpolarization levels. 1d, with a 4 J, and 1b with a 3 J coupling, and triply 2 H-labelled 1g also perform less well than 1e and 1f which can readily be explained by their poor T 1 values. Hence we conclude that locating one proton next to the N-binding site (for strong coupling to the hydride ligands) and a longer-range coupling to a second longer-lived storage site is optimal.
Optimizing the SABRE catalysis of methyl nicotinate
As the amide protons of nicotinamide are likely to play a role in these relaxation processes the series of related methyl nicotinates 2a-2e, shown in Table 2 6 solution where a 55% increase in enhancement is observed at 5.5 bar of p-H 2 when compared to 3.0 bar. This results in a 41.7% polarization being measured on the H-2 site of 2b under these conditions. These conditions are not used in the routine experiments we have described as they take the sample close to its safe pressure limit, and we would encourage any one repeating this work to take appropriate precautions. 
Increasing SABRE hyperpolarization by using a co-ligand
Our final consideration in optimizing SABRE catalysis was to overcome the presence of multiple copies of the agent being attached simultaneously to a single iridium center and thus diluting any polarization coming from p-H 2 . This would require a catalyst redesign, but if a co-ligand is added which cannot itself receive polarization a suitable test scenario can be established. Thus, SABRE hyperpolarization was conducted using a single equivalent of 2b and three equivalents of methyl-2,4,5,6-d 4 -nicotinate, relative to [IrCl(COD)(d 22 -IMes)] under 5.5 bar p-H 2 pressure. This led to 50% polarization being achieved in the H-2 site of 2b, with an average of 45% across the two sites. This is a truly remarkable result as it is delivered after just 10 seconds of SABRE. Hence we believe that this strategy reflects a compelling route to achieve hyperpolarization which can undoubtedly be improved on even further through higher pressures and a superior catalyst.
Solvent effect on relaxation times
The efficiency of SABRE catalysis has been shown to be highly dependent on the solvent, with low hyperpolarization levels resulting in 100% D 2 O solutions despite the development of water soluble catalysts.(32, 33, 36, 37) We suggest that hyperpolarization in an ethanol-d 6 solution followed by sample dilution to obtain a biocompatible bolus for injection reflects a sensible route to obtain the required signal strength for in vivo study. The T 1 values of 2b were measured in ethanol-d 6 −D 2 O solvent mixtures (see supporting information). Despite the reduction in T 1 values for the H-2 and H-5 signals of 2b in the mixed solvent systems, in a biocompatible mixture of 10% ethanol-d 6 in D 2 O the T 1 value for H-5 remains above 30 seconds. Hence very high levels of hyperpolarization are expected to survive the point of injection. We have measured the T 1 values of H-2 and H-5 in 2b in water (containing 5% D 2 O) at 9.4 T, and they fall to 6.6 and 9.3 s respectively. These values suggest that a detectable signal will be visible in vivo for at least 20 s, although if these approached were to be used in drug/urine screening or in analytical NMR more generally there would be no issue with the decay of signal prior to measurement.
Expanding the range of substrates
We have also established the generality of this method by testing a range of additional substrates. To capture a suitable cross section of targets, we have employed materials bearing the nitrogen heterocyclic motifs, pyridazine (3), pyrimidine (4) and pyrazine (5) alongside isonicotinamide (6) . The best performing isotopologues are presented in Fig. 6 and full data, including effective T 1 relaxation times in the presence of the catalyst can be found in the supporting information. In all cases, the relaxation times and polarization levels are increased. For 3,5-d 2 -pyridazine (3a), the relaxation time is increased by 550% and the polarization level by 1630% relative to pyridazine (3). Similar effects were found for pyrimidine (4) , where the deuterated isotopologue 4a yields 4.8% polarization and a signal with a T 1 value of over 2 minutes. Comparison of pyrazine (5) to 2,5-d 2 -pyrazine (5a) shows a relaxation time increase from 32.3 seconds to 86.2 seconds and a polarization level improvement from 3.3% to 11.6%. Finally, 2,5-d 2 -isonicotinamide (6a) gives a ca. 5-fold improvement in T 1 and 80-and 6-fold improvements in polarization levels for H-3 and H-6 respectively over 6.
These data show, therefore, that the strategy we detail to optimize the SABRE technology is applicable to a broad range of structural motifs and we suggest that most agents that have a need to be studied using either analytical NMR or in a clinical setting will benefit from isotope labelling. 
Assessing the impact of these changes for MRI detection
Images of the resultant SABRE derived 1 H magnetization of 1 and 2, and their better performing deuterated analogues, have been collected at 9.4 T in conjunction with a 100 mM substrate concentration in ethanol-d 6 . Analogous results under reversible flow, where measurement-repeat is possible, are also detailed in the supporting information and confirm that deuteration not only improves the resultant image intensity relative to their parents but also extends the duration over which visible signals can be detected. The longer T 1 values that these agents exhibit which act to inhibit standard multi-pulse-recovery observations are now of benefit because they should enable detection after in-vivo injection and transport to a region of clinical interest. Additionally, this change allows longer echo times to be employed which results in a lower duty cycle and radio frequency deposition rate.
We have also been able to show that when high-contrast is desired, hyperpolarized signals can be observed in the presence of a water phantom whose signal can initially be suppressed to further improve the dynamic range of the image. In the cases of 1f and 2b, the hyperpolarized agents are visible 30 seconds after completion of the polarization step with superior image intensity than that of the residual water signal. Furthermore, when 2b was examined after polarization transfer by [IrCl(COD(d 22 -IMes)] under 7 bar of p-H 2 the corresponding RARE(38) images of the same samples under normal conditions would take 9 and 40 days of continuous averaging in ethanol-d 6 and methanol-d 4 respectively to reproduce the hyperpolarized results ( Fig. 7 ) that are collected less than 20 seconds after the start of hyperpolarization. Hence we can conclude that the MRI assessment of these agents without hyperpolarization would be impractical. We also compared these data to that obtained for an excised spleen and noted a 30-fold S/N improvement relative to the tissue's H 2 O signal. 
Conclusions
The results presented here suggest that placing a proton next to nitrogen is most desirable for efficient magnetization transfer via SABRE while having an isolated proton environment is desirable for a long signal lifetime. In the case of nicotinamide (1) and methyl nicotinate (2), the deuterated forms that hyperpolarize optimally correspond to 1f and 2b. This is because polarization flows from the hydride ligands in the catalyst through to the bound substrates receptor protons optimally when both their spin-spin coupling and relaxation times are maximized. When [IrCl(COD)(IMes)] is used as the catalyst precursor, 10% polarization in 2b was achieved for H-2. It has also been shown that the catalyst also relaxes the hyperpolarization it creates, an effect which can be reduced when it is 2 H-labelled which more than doubles the level of delivered hyperpolarization to 22% when [IrCl(COD)(d 22 -IMes)] is employed. Increasing the p-H 2 pressure from 3 to 5.5 bar further increases this to 41%, while 50% H-2 polarization of 2b can be achieved with the co-ligand methyl-2,4,5,6-d 4 -nicotinate.
Given that the hyperpolarization process associated with SABRE is continuous,(23, 39) we predict it would be possible to complete any offline analyses needed to establish viability for future in vivo use, such as a pH assessment, prior to injection and the start of relaxation. Furthermore, by using the synthetic strategy we have described a hyperpolarized agent with ca. 50 % magnetic state purity (longitudinal magnetization), which is 100,000 times bigger than the 0.0005% level of a 1.5 T hospital scanner, has been produced on a single spin in just a few seconds. The resulting hyperpolarized and slowly relaxing magnetization has also been harnessed productively in a series of MRI experiments that establish these performance improvements are maintained and that our optimized agents can deliver signals which are over one order of magnitude stronger than that of biological tissue. In order to harness these results, an automated delivery system needs to be assembled to enable the injection of these agents which integrates the final steps of sample dilution and catalyst deactivation and removal to ensure biocompatibility. We also expect that these levels of enhancement can be increased still further under conditions where p-H 2 is no longer limiting. We are currently using this approach to optimally polarize Consequently, if we were to assume that 20 seconds are required from the point of injection to starting an MRI measurement, for a nominal initial polarization level of 50% we would be left with ca. 7% if the T 1 value was maintained at 10 seconds in vivo. For comparison purposes, pyruvate, delivered with a typical 30% 13 C polarization level and an in vivo T 1 of 30 seconds retains 11% polarization at this point.(40) The levels of polarization achieved here by SABRE is therefore fully commensurate with that needed for future in vivo success, particularly given the higher sensitivity of 1 H nuclei, rather than 13 C nuclei.
At a molecular level, we have developed and demonstrated a strategy to optimize the detection levels of a SABREhyperpolarized biomarker. This has required the production of a range of 2 H-labelled substrates, and the selection of their optimal form based on their relaxation time and SABRE hyperpolarization level. A combination of these procedures, with subsequent sample dilution, reflects a viable route to produce a biocompatible bolus for in vivo measurement. We are also using this approach to improve on low concentration NMR detectability for analytical purposes in a similar way. Furthermore, by illustrating the success of this approach for a variety of agents we believe that we articulate a general strategy to maximize both polarization amplitude and lifetime which will be useful to others.
Materials and Methods
Synthesis and Reactivity Studies All reactions utilizing air-and moisture-sensitive reagents were performed in dried glassware under an atmosphere of dry nitrogen. Dry solvents (THF, Toluene and DCM) were obtained from a Braun MB-SPS-800. For thin-layer chromatography (TLC) analysis, Merck pre-coated plates (silica gel 60 F254, Art 5715, 0.25 mm) were used. Column chromatography was performed on Fluka Silica gel (60 Å, 220-440 mesh). Deuterated solvents (methanol-d 4 , ethanol-d 6 and D 2 O) were obtained from Sigma-Aldrich and used as supplied. Detailed synthetic procedures and characterization data can be found in the supplementary material.
Hyperpolarization studies
1 H NMR spectra in addition to the relaxation data were measured on a Bruker 400 MHz spectrometer. SABRE hyperpolarization transfer experiments involved p-H 2 that was produced by cooling H 2 gas over Fe 2 O 3 at 30 K. Samples contained 5 mM concentrations of the catalyst and 5 up to 20 equivalents of substrate relative to iridium in the specified solvent in a 5 NMR tube fitted with a J. Young's Tap. The resulting solutions were degassed prior to the introduction of p-H 2 at a pressure of 3 bar unless otherwise stated. Samples were shaken for 7 seconds in a specified fringe field of a 9.4 T Bruker Avance (III) NMR spectrometer for hyperpolarization transfer prior to being rapidly transported into the main magnetic field of the instrument for subsequent probing by NMR or MRI methods. The associated polarization transfer experiment data can be found in the supplementary material.
Statistical Analysis
Errors have been calculated using the standard deviation formula, taking into account the limited number of population samples. Gaussian error propagation has been assumed (see supporting information).
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General
Water is distilled water. Brine refers to a saturated aqueous solution of NaCl. THF was freshly distilled from sodium and benzophenone ketyl or dried using a Grubbs solvent purification system. Petrol refers to the fraction of petroleum ether boiling in the range 40-60 °C. All reactions were carried out under O 2 -free Ar or N 2 using oven-dried and/or flamedried glassware.
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-440 mesh 
13
C NMR spectra were recorded with broadband proton decoupling. 13 C NMR spectra were assigned using DEPT experiments where necessary. Coupling constants (J) are quoted in Hertz. Electrospray high and low resolution mass spectra were recorded on a Bruker Daltonics microOTOF spectrometer.
All compounds were purchased from Sigma-Aldrich, Fluorochem or Alfa-Aesar and used as supplied unless otherwise stated. The following compounds were synthesised according to literature procedures; methyl-2,4-dichloronicotinate,(1) ethyl-4,5,6-trichloronicotinate, (2) and [IrCl(COD)(IMes)].(3)
General Procedures
General Procedure A -Deuteration of heteroaryl chlorides 5% Pd/C (10 wt%) was added to a stirred suspension of heteroaryl chloride (1.0 eq.) and K 2 CO 3 (2.5 -3.5 eq.) in MeOD (10 mL) or EtOD (10 mL) in a 30 mL Parr Reactor. The Parr reactor was sealed, purged with N 2(g) and pressurised with D 2(g) (5 bar). The reaction was then stirred at rt for 3 h. Then, the pressure was released and the suspension was filtered through Celite® and washed with CH 2 Cl 2 . The filtrate was concentrated under reduced pressure to give the crude product.
General Procedure B -Synthesis of nicotinamide by amide formation
The nicotinate (1.0 eq) was dissolved in ammonia (10 mL of a 7 N solution in MeOH) and the resulting solution stirred at rt for 2 days. The solution was concentrated under reduced pressure to give the crude product. S13
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Methyl-2,6-d 2 -nicotinate S1
Using General Procedure A, methyl-2,6-dichloronicotinate (100 mg, 0.485 mmol, 1.0 eq.), 5% Pd/C (10 mg, 10 wt%), K 2 CO 3 (167 mg, 1.21 mmol, 2.5 eq.) and D 2(g) (5 bar) in THF (10 mL) gave the crude product. Purification by flash column chromatography with 1:1 petrolEtOAc as eluent gave methyl-2,6-d 2 
2,6-d 2 -Nicotinamide 1a
Using General Procedure B, methyl-2,6-d 2 -nicotinate S1 (45 mg, 0.324 mmol) in ammonia (6 mL of a 7 N solution in MeOH) gave the crude product. Purification by reverse phase flash column chromatography (0-30% MeCN) gave 2,6-d 2 -nicotinamide 1a (34 mg, 85%) as a white solid, 
Ethyl-2,4-d 2 -nicotinate S2
Using General Procedure A, methyl-2,4-dichloronicotinate(1) (135 mg, 0.65 mmol, 1.0 eq.), 5% Pd/C (14 mg, 10 wt%), K 2 CO 3 (250 mg, 2.75 mmol, 2.5 eq.) and D 2(g) (5 bar) in EtOD (10 mL) gave the crude product. Purification by flash column chromatography with 1:1 petrolEtOAc as eluent gave ethyl-2,4-d 2 
2,4-d 2 -Nicotinamide 1b
Using General Procedure B, ethyl 2,4-d 2 -nicotinate S2 (62 mg, 0.406 mmol) in ammonia (5 mL of a 7 N solution in MeOH) gave the crude product. Purification by reverse phase flash column chromatography (0-30% MeCN) gave 2,4-d 2 -nicotinamide 1b (50 mg, 100%) as a white solid, 
3-Bromo-2,4,5,6-d 4 -pyridine N-oxide S3
A solution of 3-bromopyridine N-oxide (1.07 g, 6.15 mmol), NaOH (100 mg, 2.5 mmol, 0.4 eq.) and D 2 O (10 mL) was heated to 180 °C in a microwave for 1 h. The reaction was concentrated under reduced pressure and refreshed with D 2 O (10 mL), then heated to 180 °C for a further hour in a microwave. The solvent was removed under reduced pressure and the process repeated an additional time. The reaction was subsequently concentrated under reduced pressure and dissolved in CH 2 Cl 2 (50 mL), dried over MgSO 4(s) , filtered and concentrated under reduced pressure to afford 3-bromo-2,4,5,6-d 4 -pyridine N-oxide S3 (1.05 g, 96%) as a pale yellow oil which was used without further purification, 
Methyl 4,5-d 2 -nicotinate N-oxide S5
A solution of 3-bromo-4,5-d 2 -pyridine N-oxide S4 (180 mg, 1.02 mmol), Et 3 N (1 mL, 13.6 mmol, 13.3 eq.), PdCl 2 (dppf) (20 mg, 0.025 mmol, 2.5 mol%) and MeOH (10 mL) was heated to 75 °C under CO (g) (4 Bar) for 4 h. The reaction was allowed to cool and concentrated under reduced pressure to afford the crude product. Purification by flash column chromatography (0-10% MeOH in CH 2 Cl 2 ) gave methyl-4,5-d 2 
5-Bromo-2-chloronicotinamide S8
A solution of methyl 5-bromo-2-chloronicotinate (250 mg, 1 mmol) was dissolved in ammonia (5 mL of a 7 N solution in MeOH) and the resulting solution stirred at rt for 16 h. Concentration under reduced pressure afforded 5-bromo-2-chloronicotinamide S8 (235 mg, 100%) as a crystalline white solid, used without further purification. 
Methyl-2,5-d 2 -nicotinate 1e
Using General Procedure A, 5-bromo-2-chloronicotinamide S8 (100 mg, 0.425 mmol, 1.0 eq.), 5% Pd/C (20 mg, 20 wt%), K 2 CO 3 (150 mg, 1.09 mmol, 2.5 eq.) and D 2(g) (7 bar) in EtOD (10 mL) gave the crude product.
Purification by reverse phase flash column chromatography (0-30% MeCN) gave 2,5-d 2 5% Pd/C (50 mg, 10 wt%) was added to a stirred suspension of 4,6-dichloronicotinic acid (500 mg, 2.63 mmol, 1.0 eq.) and K 2 CO 3 (910 mg, 6.58 mmol, 2.5 eq.) in a 1:1 mix of THF-D 2 O (14 mL) in a 30 mL Parr Reactor. The Parr reactor was sealed, purged with N 2(g) and pressurised with D 2(g) (8 bar). The reaction was stirred at rt for 16h. Then, the pressure was released and the suspension was filtered through Celite® and washed with CH 2 Cl 2 (3 x 15 mL). The filtrate was concentrated under reduced pressure to give a solid residue that was dissolved in CH 2 Cl 2 (10 mL). Then, oxaloyl chloride (265 µL, 3.16 mmol, 1.2 eq.) and DMF (2 drops) were added and the resulting solution was stirred at rt for 1 h. The reaction was concentrated under reduced pressure and CH 2 Cl 2 (10 mL), Et 3 N (857 µL, 6.58 mmol, 2.5 eq.) and CD 3 OD (1.0 mL) were added sequentially. The resulting solution was stirred at rt for 10 min. The aqueous layer was extracted with CH 2 Cl 2 (2 x 10 mL). The combined organic layers were dried (MgSO 4 ) and concentrated under reduced pressure to give the crude product. 
Methyl-2,4-d 2 -nicotinate 2d
5% Pd/C (50 mg, 10 wt%) was added to a stirred suspension of 2,5-dichloronicotinic acid (500 mg, 2.63 mmol, 1.0 eq.) and K 2 CO 3 (910 mg, 6.58 mmol, 2.5 eq.) in a 1:1 mix of THF-D 2 O (14 mL) in a 30 mL Parr Reactor. The Parr reactor was sealed, purged with N 2(g) and pressurised with D 2(g) (8 bar) . The reaction was stirred at rt for 16h. Then, the pressure was released and the suspension was filtered through Celite® and washed with CH 2 Cl 2 (3 x 15 S21 mL). The filtrate was concentrated under reduced pressure to give a solid residue that was dissolved in CH 2 Cl 2 (10 mL). Then, oxalyl chloride (265 µL, 3.16 mmol, 1.2 eq.) and DMF (2 drops) were added and the resulting solution was stirred at rt for 1 h. The reaction was concentrated under reduced pressure and CH 2 Cl 2 (10 mL), Et 3 N (857 µL, 6.58 mmol, 2.5 eq.) and MeOH (1.0 mL) were added sequentially. The resulting solution was stirred at rt for 10 min. The aqueous layer was extracted with CH 2 Cl 2 (2 x 10 mL). The combined organic layers were dried (MgSO 4 ) and concentrated under reduced pressure to give the crude product. Purification by flash column chromatography with 1:1 petrol-EtOAc as eluent gave methyl-2,5-d 2 -nicotinate 2d (293 mg,72%) as a pale yellow solid, R F (1:1 petrol-EtOAc) 0.3; 
Methyl-2,5-d 2 -nicotinate 2e
5% Pd/C (50 mg, 10 wt%) was added to a stirred suspension of 2,5-dichloronicotinic acid (500 mg, 2.63 mmol, 1.0 eq.) and K 2 CO 3 (910 mg, 6.58 mmol, 2.5 eq.) in a 1:1 mix of THF-D 2 O (14 mL) in a 30 mL Parr Reactor. The Parr reactor was sealed, purged with N 2(g) and pressurised with D 2(g) (8 bar). The reaction was stirred at rt for 16h. Then, the pressure was released and the suspension was filtered through Celite® and washed with CH 2 Cl 2 (3 x 15 mL). The filtrate was concentrated under reduced pressure to give a solid residue that was dissolved in CH 2 Cl 2 (10 mL). Then, oxalyl chloride (265 µL, 3.16 mmol, 1.2 eq.) and DMF (2 drops) were added and the resulting solution was stirred at rt for 1 h. The reaction was concentrated under reduced pressure and CH 2 Cl 2 (10 mL), Et 3 N (857 µL, 6.58 mmol, 2.5 eq.) and MeOH (1.0 mL) were added sequentially. The resulting solution was stirred at rt for 10 min. The aqueous layer was extracted with CH 2 Cl 2 (2 x 10 mL). The combined organic layers were dried (MgSO 4 ) and concentrated under reduced pressure to give the crude product. Purification by flash column chromatography with 1:1 petrol-EtOAc as eluent gave methyl-2,5-d 2 -nicotinate 2e (253 mg, 62%) as a pale yellow solid, R F (1:1 petrol-EtOAc) 0.3; 02 mmol, 1.3eq.), PdCl 2 (dppf) (244 mg, 0.31 mmol,5 mol%) and MeOH (30 mL) was heated to 75 °C under CO (g) (4 Bar) for 4 h. The reaction was allowed to cool and concentrated under reduced pressure to afford the crude product. The residue was dissolved in CH 2 Cl 2 (30 mL) and PCl 3 (2.0 mL) was added. Then, the reaction was heated to 40 °C for 2 h. The reaction was allowed to cool and quenched by careful addition onto ice. The resulting solution was adjusted to pH > 7 by addition of NaHCO 3(s) and extracted with CH 2 Cl 2 (3 × 50 mL). The combined extracts were concentrated under reduced pressure to afford the crude product. Purification by flash column chromatography (1:1 hexane-EtOAc) gave methyl 2,4,5,6-d 4 
2,5-d 2 -pyrimidine 4a
To a suspension of 2,5-dichloropyrimidine (500 mg, 3.4 mmol, 1.0 eq.) and K 2 CO 3 (1.4 g, 10 mmol, 3 eq.) in THF (5 mL) and D 2 O (5 mL) in a 30 mL Parr reactor was added 5% Pd/C (50 mg, 10 wt%). The reactor was sealed, purged with N 2 , then pressurised with D 2 (8 bar). The reaction mixture was stirred at room temperature for 1 hour. The pressure was released and the suspension was filtered through Celite® and washed with diethyl ether (20 mL). The filtrate was washed with brine (20 mL), dried over MgSO 4 then acidified with HCl (2 M in diethyl ether, 2 mL). The resulting suspension was decanted to leave an oily residue which solidified under a stream of nitrogen. This solid was dissolved in methanol-d 4 
2,5-d 2 -pyrazine 5a
To a suspension of 2,5-dichloropyrazine (500 mg, 3.4 mmol, 1.0 eq.) and K 2 CO 3 (925 mg, 6.7 mmol, 2 eq.) in THF (5 mL) and D 2 O (5 mL) in a 30 mL Parr reactor was added 5% Pd/C (50 mg, 10 wt%). The reactor was sealed, purged with N 2 , then pressurised with D 2 (8 bar). The reaction mixture was stirred at room temperature for 1 hour. The pressure was released 
Methyl 2,5-dichloroisonicotinate S9
To a solution of 2,5-dichloroisonicotinic acid (500 mg, 2.6 mmol, 1.0 eq.) in methanol (5 mL) and diethyl ether (5 mL) was added (trimethylsilyl)diazomethane solution (2.6 mL, 2.0 M in diethyl ether, 2 eq.). The reaction mixture was stirred at room temperature for 30 minutes, then concentrated under reduced pressure and purified by flash column chromatography with 4:1 petrol-EtOAc as eluent to give methyl 2,5-dichloroisonicotinate S9 (518 mg, 97%) as a colourless solid, 
Ethyl 2,5-d 2 -isonicotinate S10
To a suspension of methyl 2,5-dichloroisonicotinate (500 mg, 2.4 mmol, 1.0 eq.) and K 2 CO 3 (850 mg, 6.2 mmol, 2.5 eq.) in EtOD (10 mL) in a 30 mL Parr reactor was added 5% Pd/C (50 mg, 10 wt%). The reactor was sealed, purged with N 2 , then pressurised with D 2 (8 bar). The reaction mixture was stirred at room temperature for 4 hours. The pressure was released and the suspension was filtered through Celite® and washed with EtOH. The filtrate was concentrated under reduced pressure and purified by flash column chromatography with 1:1 petrol-EtOAc as eluent to give ethyl 2,5-d 2 -isonicotinate S10 (268 mg, 72%) as a colourless oil, 
NMR polarization transfer experiments
Polarization transfer methods
The polarization transfer experiments that are reported were conducted in either an NMR tube that was equipped with a Young's Tap (Method A) or using an automated polarizer (Method B).
Method A
Samples for these polarization transfer experiments were based on a 5 mM solution of [IrCl(COD)(IMes)] and substrate in methanol-d 4 or ethanol-d 6 (0.6 mL). The samples were degassed prior to the introduction of parahydrogen at the required pressure. Samples were then shaken for 10 s in the specified fringe field of an NMR spectrometer before being rapidly transported into the magnet for subsequent interrogation by NMR spectroscopy.
Method B
For the automated polarizer measurements, samples consisted of [IrCl(COD)(IMes)] and the substrate in methanol-d 4 solution (3mL). A schematic representation of the polarizer used for flow measurements is shown in Figure S1 . The Mixing Chamber (MC) is housed within a tuneable copper coil (0.5 to ±150 G). The coil was situated in a magnetic field which has the components x 4.9 -5.1 G, y 3.3 -3.6 G and z 1.5 -2.1 G. All magnitudes of the magnetic fields in which polarization transfer occurs (PTF) are stated without correction for this local field). The MC houses the solvent, catalyst and substrate. Liquid and gas flow is computercontrolled via the pulse program. As such, the system is entirely automated. Parahydrogen is introduced into the MC first to activate the catalyst. Nitrogen gas is used to shuttle the hyperpolarized solution from the MC to the NMR probe head for measurement. The transportation time was calibrated to 2.9 s. A further delay of 0.5 s was allowed for settling of the sample prior to signal acquisition (1 s).
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Fig. S1: Schematic representation of the polarizer, the hyperpolarization process and its subsequent NMR analysis.
1 H Enhancement factors calculations and statistical analysis
For calculation of the enhancement of 1 H NMR signals the following formula was used:
Where, E = enhancement, SI(pol) = signal of polarized sample, SI(unpol) = signal of unpolarized (reference) sample. Experimentally, both spectra were recorded on the same sample using identical acquisition parameters, including the receiver gain. The raw integrals of the relevant resonances in the polarized and unpolarized spectra were then used to determine the enhancement levels. Errors corresponding to the determination of the enhancement of individual sites have been calculated using the standard deviation formula ∑ ̅
where ̅ is the sample mean average of the enhancements obtained after performing several experiments on the same sample and n is the number of experiments (typically between 5 and 7). The values obtained for each site were used in the calculation of the S30 errors for the total enhancement using the well-known method for the propagation of uncertainty. 
Representative 1 H NMR spectra of the SABRE effect in deuterated agents
Polarisation transfer results for the specified IMes catalysts
Use of methyl-2,4,5,6-d 4 nicotinate as a co-substrate
Methyl-2,4,5,6-d 4 -nicotinate was used as a co-substrate to further reduce spin dilution in the active catalyst to achieve optimal polarisation of 2b. A sample containing 5 mM of [IrCl(COD)(d 22 -IMes)], 1 equivalent of 2b and 3 equivalents of methyl-2,4,5,6-d 4 -nicotinate in methanol-d 4 (0.6 mL) was prepared and exposed to increasing pressures of p-H 2 as shown in Table S3 . 
Kinetic behaviour of 2b with [IrCl(COD(NHC)] under H 2
The kinetic behaviour of 2b with [IrCl(COD)(IMes)] and [IrCl(COD)(d 22 -IMes)] under 3 bar H 2 was examined using exchange spectroscopy, as follows.
A series of exchange spectroscopy (EXSY) measurements were performed to probe the dynamic behaviour of these systems. This process involved the selective excitation of a single resonance and the subsequent measurement of a 1 H NMR spectrum at time, t, after the initial pulse. The resulting measurements consisted of a series of data arrays such that t is varied typically between 0.1 to 1.0 s, to encode the reaction profile. The precise values were varied with temperature to suit the speed of the process. Data was collected for a range of temperatures and sample concentrations. Integrals for the interchanging peaks in the associated 1 H EXSY spectra were obtained and converted into a percentage of the total detected signal.
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These data were then analysed as a function of the mixing time according to a differential kinetic model [10] . Rates of exchange were determined by employing a Runge-Kutta (6, 7) scheme to solve the system of differential equations and a Levenberg-Marquardt algorithm (8, 9) to minimize the sum of the residuals in the associated least mean squares analysis. The theoretical model used to fit the experimental EXSY data involved a two-site exchange (A ↔ B), as expressed by the equations below: * * * * An example of typical build-up/decay curves obtained from the integration of the experimental EXSY data, together with the corresponding fitted data is presented below. 
T 1 relaxation data for 2b in ethanol-d 6 :D 2 O solvent mixtures
The relaxation rate of 2b in varying mixtures of ethanol-d 6 :D 2 O was recorded using inversion recovery at 9.4 T. These data are presented in Fig. S6 . 
T 1 relaxation data in H 2 O solution containing 5% D 2 O
The relaxation of each of the substrates was also monitored in 95% H 2 O 5% D 2 O solution using an inversion recovery sequence with water suppression at 9.4 T. These data are presented in Table s5. ).
Solvent suppression was accomplished by using a VAPOR (variable power and optimized relaxation delays(12)) train of pulses centred on the water resonance, with a wide bandwidth, which covered not only the H 2 O signal but also the signals coming from the residual protons in the deuterated solvents. The total duration of the suppression module was 660 ms.
MRI data processing and statistical analysis
All results were processed using Bruker software (Paravision 5.1) and home-developed post processing routines written in MATLAB. Prior to Fourier transformation, data were zero-filled once (final matrix size 128 x 128) and a sine bell squared filter was applied.
Signal-to-noise values were calculated using the ratio between the mean of the signal and the standard deviation of the noise. In most cases the values obtained for the selectively deuterated substrates are expressed as relative to the corresponding values obtained for the protio molecule. 
Results
Image intensity optimisation through selective deuteration
Effects of relaxation on image quality
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In order to probe the effect of relaxation on the image intensity, a set of images of each sample was acquired in identical conditions but with variable delays before the transfer of the sample in the magnet. The purpose of this was to estimate the effective signal left after various times from the end of the polarisation process, as would be required in real life applications (delivery through an injection or catheter) in which the delivery speed needs to be adjusted according to clinical requirements. The waiting times employed were adjusted as a function of the substrate's relaxation rate and were typically between 0 and 30 s. A centric sampling of the k-space was employed to minimise the effect the transverse relaxation might have on the signal. 
A). B). C). D).
Fig. S15 Images of a 5 mm water tube and 100 mM 2b in EtOD. The images were acquired using a water suppression scheme A). 10 s, B). 15 s, C). 20 s and D). 30 s after the polarisation transfer process.
Effects of pH 2 pressure on image quality
S40
The effects of pH 2 pressure on image intensity and contrast were tested using a pressure resistant tube and the substrates 1f and 2b. The results are presented below. 
